$7.30
-6.57[-47.37%]
Last update: 4:57PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$7.30
0[0.00%]
| Open- | Close- |
| Vol / Avg.0 / 3.392K | Mkt Cap- |
| Day Range- - - | 52 Wk Range0.018 - 44.145 |
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLGW), Key Statistics
Bone Biologics Stock (NASDAQ: BBLGW) analysis, key statistics.
Valuation Measures
Enterprise Value
- -
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -